GlassScriptPhysician profile
David W Amory
NPI 1659358786
$6,755.83
in general payments reported to CMS, 2019-2025
8 companies · $3,983 in 2025
The $3,983 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $981 · 2020: $57.39 · 2022: $24.95 · 2023: $911 · 2024: $798 · 2025: $3,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,466 · Food and Beverage: $2,017 · Travel and Lodging: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,465.91 |
| Food and Beverage | $2,016.62 |
| Travel and Lodging | $209.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,675.61 | 2019-2025 | Mako, Accolade, Triathlon |
| Encore Medical, LP | $869.77 | 2019 | |
| Pacira Therapeutics, INC. | $64.33 | 2019 | |
| Depuy Synthes Sales INC. | $47.07 | 2023 | Orthovisc |
| Boston Scientific Corporation | $34.50 | 2020 | |
| Sanofi-Aventis U.S. LLC | $24.95 | 2022 | |
| Medtronic USA, INC. | $22.89 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.71 | 2023 | Zilretta, Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Amory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.